Notice Pursuant to the National Cooperative Research and Production Act of 1993-Electrified Vehicle and Energy Storage Evaluation, 58691 [2021-23098]
Download as PDF
<![CDATA[
58691
Federal Register / Vol. 86, No. 202 / Friday, October 22, 2021 / Notices
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Electrified Vehicle and
Energy Storage Evaluation
Notice is hereby given that, on
September 21, 2021, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Electrified Vehicle and Energy Storage
Evaluation (‘‘EVESE’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, LG Energy Solution, Ltd.,
Seoul, KOREA, has been added as a
party to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and EVESE
intends to file additional written
notifications disclosing all changes in
membership.
On September 24, 2020, EVESE filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on October 15, 2020 (85
FR 65423).
The last notification was filed with
the Department on July 27, 2021. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on August 23, 2021 (86 FR 47157).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2021–23098 Filed 10–21–21; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
lotter on DSK11XQN23PROD with NOTICES1
[Docket No. DEA–913]
Bulk Manufacturer of Controlled
Substances Application: Chattem
Chemicals
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Chattem Chemicals has
applied to be registered as a bulk
SUMMARY:
VerDate Sep<11>2014
17:47 Oct 21, 2021
Jkt 256001
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 21, 2021. Such
persons may also file a written request
for a hearing on the application on or
before December 21, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 23, 2021, Chattem
Chemicals, 3801 Saint Elmo Avenue,
Chattanooga, Tennessee 37409–1237,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Gamma Hydroxybutyric Acid ....
Marihuana .................................
Tetrahydrocannabinols .............
4-Methoxyamphetamine ...........
Noroxymorphone ......................
Amphetamine ............................
Methamphetamine ....................
Lisdexamfetamine .....................
Methylphenidate ........................
Cocaine .....................................
Codeine .....................................
Dihydrocodeine .........................
Oxycodone ................................
Hydromorphone ........................
Ecgonine ...................................
Hydrocodone .............................
Levorphanol ..............................
Methadone ................................
Methadone intermediate ...........
Morphine ...................................
Oripavine ...................................
Thebaine ...................................
Oxymorphone ...........................
Noroxymorphone ......................
Alfentanil ...................................
Remifentanil ..............................
Sufentanil ..................................
Tapentadol ................................
Fentanyl ....................................
Drug
code
Schedule
2010
7360
7370
7411
9145
1100
1105
1205
1724
9041
9050
9120
9143
9150
9180
9193
9220
9250
9254
9300
9330
9333
9652
9668
9737
9739
9740
9780
9801
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution and sale to its
customers. In reference to drug code
7360 (Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as a synthetic.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
No other activities for this drug code
are authorized for this registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–23037 Filed 10–21–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–919]
Importer of Controlled Substances
Application: Mycrodose Therapeutics
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Mycrodose Therapeutics has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 22, 2021. Such
persons may also file a written request
for a hearing on the application on or
before November 22, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on September 17, 2021,
Mycrodose Therapeutics, 5940 Pacific
Mesa Court, Suite 210, San Diego,
California 92121–4317 applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUMMARY:
Controlled substance
Psilocybin ........................
Psilocyn ...........................
E:\FR\FM\22OCN1.SGM
22OCN1
I
Drug
code
Schedule
7437
7438
I
I
I
]]>Agencies
[Federal Register Volume 86, Number 202 (Friday, October 22, 2021)]
[Notices]
[Page 58691]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23098]
[[Page 58691]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Electrified Vehicle and Energy Storage
Evaluation
Notice is hereby given that, on September 21, 2021, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Electrified Vehicle and
Energy Storage Evaluation (``EVESE'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing changes in its membership. The notifications were
filed for the purpose of extending the Act's provisions limiting the
recovery of antitrust plaintiffs to actual damages under specified
circumstances. Specifically, LG Energy Solution, Ltd., Seoul, KOREA,
has been added as a party to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and EVESE intends to file additional
written notifications disclosing all changes in membership.
On September 24, 2020, EVESE filed its original notification
pursuant to Section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to Section 6(b) of
the Act on October 15, 2020 (85 FR 65423).
The last notification was filed with the Department on July 27,
2021. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on August 23, 2021 (86 FR 47157).
Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2021-23098 Filed 10-21-21; 8:45 am]
BILLING CODE 4410-11-P
